Click here to BLOCK YOUR CONTENT SPACE IN OUR NEXT ISSUES
|
| |
 |
Market Trends |
|
| |
Tech Trends And Estimates For The Pharmaceutical Industry In 2023
Partnerships and cooperation between pharmaceutical powerhouses and providers of AI technology increased in 2022, and this trend is anticipated to persist.
|
|
|
|
| |
|
|
| |
|
|
Innovations In Quality Control For Pharmaceutical Production
Pharma is shifting to biotech and individualised medications, and novel remedies are being developed, affecting quality monitoring, oversight, and assurance.
|
|
| |
|
|
| |
6 Pharma, Biotech Patent Litigation Trends To Watch In 2023
Nearing the end of 2022, six factors relating to the patent disputes in the pharmaceutical & biotechnology sectors will be of paramount importance in 2023.
|
|
|
|
|
|
|
| |
 |
Industry Insights |
|
| |
|
|
WHO Report Says That AMR Surveillance Has To Be Strengthened
For the first time since 2017, AMR trends are presented in the Global Antimicrobial Resistance and Use Survei-llance System - GLASS analysis by WHO for 2022
|
|
| |
|
|
| |
National Database of Drug Formulations In India A Priority
Ministry of Health and Family Welfare wants to build a database of drug formulations which has dosage form, potency, and maker, marketer, importer information.
|
|
|
|
| |
|
|
| |
|
|
New Zealand Health Groups Strive To Enhance Clinical Trials
Enhancing Aotearoa New Zealand Clinical Trials urges that top health agencies in New Zealand look into systemic reforms to boost benefits of clinical trials.
|
|
| |
|
|
| |
By 2027, Market For Oligonucleotides Will Be Worth $16.7 Bn
As per a new analysis, the market for oligonucleotide synthesis will reach $16.7bn by 2027 as a result of clinical trials for drugs based on oligonucleotides.
|
|
|
|
|
